ImmunityBio (IBRX) Revenue (2014 - 2026)
ImmunityBio (IBRX) posted quarterly Revenue of $44.2 million for Q1 2026, up 167.64% year-over-year from $16.5 million in Q1 2025, and up 15.47% quarter-over-quarter from $38.3 million in Q4 2025.
ImmunityBio (IBRX) Revenue (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Revenue for 13 consecutive years, with $44.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue rose 167.64% year-over-year to $44.2 million; the TTM figure through Mar 2026 stood at $141.0 million (up 351.53% YoY), while the FY2025 annual figure was $113.3 million, up 668.31% from the prior year.
- Revenue grew to $44.2 million in Q1 2026 per IBRX's latest filing, from $38.3 million in the prior quarter.
- Across five years, Revenue topped out at $44.2 million in Q1 2026 and bottomed at $14000.0 in Q1 2022.
- Historically, Revenue has averaged $10.2 million across 5 years, with a median of $360000.0 in 2023.
- Annual changes were most pronounced in 2022 — Revenue plunged 89.93% — and 2025, when it jumped 41192.5%.
- ImmunityBio's Revenue stood at $73000.0 in 2022, then jumped by 90.41% to $139000.0 in 2023, then jumped by 5333.09% to $7.6 million in 2024, then jumped by 406.95% to $38.3 million in 2025, then grew by 15.47% to $44.2 million in 2026.
- Business Quant data shows IBRX's Revenue at $44.2 million in Q1 2026, $38.3 million in Q4 2025, and $32.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | ImmunityBio | 7.97 Bn | 7.62 Bn | 50.94 Mn | 51.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.24 Mn |
| Mar 31, 2026 | 44.21 Mn |
| Dec 31, 2025 | 38.29 Mn |
| Sep 30, 2025 | 32.06 Mn |
| Jun 30, 2025 | 26.43 Mn |
| Mar 31, 2025 | 16.52 Mn |
| Dec 31, 2024 | 7.55 Mn |
| Sep 30, 2024 | 6.11 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 139,000.00 |
| Sep 30, 2023 | 82,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 360,000.00 |
| Dec 31, 2022 | 73,000.00 |
| Sep 30, 2022 | 118,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 390,000.00 |
| Sep 30, 2021 | 66,000.00 |